miRNA451a expression in AD patients has been reported to increase significantly as compared to healthy control and positively correlates with Aβ-42/Aβ-40 ratio and tau protein (Samadian et al. 2021; Kuang et al. 2018). The gene discussed is MAPT; the disease is Alzheimer disease.